<DOC>
	<DOCNO>NCT00082537</DOCNO>
	<brief_summary>This study double-blind , randomize study MK0991 versus liposomal amphotericin B empirical treatment pediatric patient ( age 2 17 year ) absolute neutrophil count ( ANC ) 500/microliter fever despite broad antibiotic coverage . Such patient would candidate empirical therapy intravenous anti-fungal agent .</brief_summary>
	<brief_title>MK0991 Versus Amphotericin B Empirical Therapy Febrile , Neutropenic Pediatric Patients ( 0991-044 )</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Patients 2 17 year age Absolute Neutrophil Count ( ANC ) 500/microliter Have persistent fever ( least 4 day ) despite antibiotic therapy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>